How to Change Your Mind | |
---|---|
Genre | Documentary |
Based on |
How to Change Your Mind by Michael Pollan |
Directed by |
|
Presented by | Michael Pollan |
Composer | Justin Melland |
Country of origin |
|
Original language | English |
No. of episodes | 4 |
Production | |
Executive producers |
|
Producers |
|
Cinematography | Pablo Berron |
Running time | 51–55 minutes |
Production companies |
|
Original release | |
Network | Netflix |
Release | July 12, 2022 |
How to Change Your Mind is a 2022 American docuseries based on the book of the same of the same name by Michael Pollan. It consists of four episodes, which were released on July 12, 2022, on Netflix and give insights into the psychedelic drugs LSD, psilocybin, MDMA and mescaline as well as their uses in psychedelic therapy. The series has been dubbed into Spanish, Hindi, Portuguese, French, Russian, German, Italian, Polish, Czech, and Hungarian.
Michael Pollan published his book How to Change Your Mind in 2018. He serves as a presenter and guide throughout the miniseries.
On June 16, 2022, Netflix first published a trailer for the series and announced that Lucy Walker and Alison Ellwood would be directing, while Alex Gibney would serve as executive producer. Gibney expressed his pleasure working on the project, adding "It’s so important—a revelation about how some hallucinogens, once vilified, can lead to mindfulness. New science shows that these drugs can save lives and change our minds, helping us to live better lives." [1]
According to director Alison Ellwood, the series tries to omit "psychedelic visual tropes—wild colors, rainbow streaks, morphing images" to make it relatable to people who have not had psychedelic experiences. [2]
No. | Title | Directed by | Original air date | |
---|---|---|---|---|
1 | "LSD" | Lucy Walker | July 12, 2022 | |
The series' premiere episode about
lysergic acid diethylamide (LSD) focuses on topics like the first synthesis of the drug in 1938,
Bicycle Day, the
Harvard Psilocybin Project,
Project MKUltra,
Acid Tests, as well as
psychedelic microdosing and
psychedelic therapy. It features interviews with
Albert Hofmann,
Humphry Osmond,
Timothy Leary,
James Fadiman,
Richard Alpert and
Ken Kesey, among others. | ||||
2 | "Psilocybin" | Lucy Walker & Alison Ellwood | July 12, 2022 | |
Topics touched on in the episode on
psilocybin and
psilocybin mushrooms include
psilocybin therapy,
curanderos, the
Seeking the Magic Mushroom article, the
Spring Grove Experiment,
scholarly approaches to mysticism, as well as the
legal status of psilocybin mushrooms and
ego death. Interviewees include
María Sabina,
R. Gordon Wasson, Albert Hofmann, Timothy Leary, William Richards,
Paul Stamets and
Roland Griffiths. | ||||
3 | "MDMA" | Alison Ellwood & Lucy Walker | July 12, 2022 | |
3,4-Methylenedioxymethamphetamine (MDMA) or "ecstasy" is the drug of focus for this episode, with a particular emphasis being placed on themes such as
MDMA-assisted psychotherapy (including
psychedelic treatments for trauma-related disorders), the
Multidisciplinary Association for Psychedelic Studies, as well as
raves and the
Second Summer of Love. Some of the prominent figures being interviewed in this episode are
Ann and
Alexander Shulgin, Ben Sessa and
Rick Doblin. | ||||
4 | "Mescaline" | Alison Ellwood & Lucy Walker | July 12, 2022 | |
The final episode about
mescaline gives insights into
peyote and the
peyote ceremony as administered by
indigenous Americans, such as adherents of the
Native American Church, as well as into the "Decriminalize Nature" movement. It mentions
Echinopsis pachanoi, and the
Eleusinian Mysteries. Some of the interviewees are
Alfred Leo Smith,
Aldous Huxley, Humphry Osmond and Timothy Leary. |
On Rotten Tomatoes, the miniseries holds an approval rating of 100% based on 9 reviews, with an average rating of 7.40/10. [3] Stuart Heritage of The Guardian called the miniseries "hugely eloquent and convincing". [4] Natalia Winkelman of The Boston Globe criticized the series for being too one-sided and failing to adequately address adverse effects of psychedelics. [5] San Francisco Chronicle critic Bob Strauss found the series "not comprehensive, but packed with interesting tidbits" and says it provided "multiple worthy views that can be mind-blowing." [6]
How to Change Your Mind | |
---|---|
Genre | Documentary |
Based on |
How to Change Your Mind by Michael Pollan |
Directed by |
|
Presented by | Michael Pollan |
Composer | Justin Melland |
Country of origin |
|
Original language | English |
No. of episodes | 4 |
Production | |
Executive producers |
|
Producers |
|
Cinematography | Pablo Berron |
Running time | 51–55 minutes |
Production companies |
|
Original release | |
Network | Netflix |
Release | July 12, 2022 |
How to Change Your Mind is a 2022 American docuseries based on the book of the same of the same name by Michael Pollan. It consists of four episodes, which were released on July 12, 2022, on Netflix and give insights into the psychedelic drugs LSD, psilocybin, MDMA and mescaline as well as their uses in psychedelic therapy. The series has been dubbed into Spanish, Hindi, Portuguese, French, Russian, German, Italian, Polish, Czech, and Hungarian.
Michael Pollan published his book How to Change Your Mind in 2018. He serves as a presenter and guide throughout the miniseries.
On June 16, 2022, Netflix first published a trailer for the series and announced that Lucy Walker and Alison Ellwood would be directing, while Alex Gibney would serve as executive producer. Gibney expressed his pleasure working on the project, adding "It’s so important—a revelation about how some hallucinogens, once vilified, can lead to mindfulness. New science shows that these drugs can save lives and change our minds, helping us to live better lives." [1]
According to director Alison Ellwood, the series tries to omit "psychedelic visual tropes—wild colors, rainbow streaks, morphing images" to make it relatable to people who have not had psychedelic experiences. [2]
No. | Title | Directed by | Original air date | |
---|---|---|---|---|
1 | "LSD" | Lucy Walker | July 12, 2022 | |
The series' premiere episode about
lysergic acid diethylamide (LSD) focuses on topics like the first synthesis of the drug in 1938,
Bicycle Day, the
Harvard Psilocybin Project,
Project MKUltra,
Acid Tests, as well as
psychedelic microdosing and
psychedelic therapy. It features interviews with
Albert Hofmann,
Humphry Osmond,
Timothy Leary,
James Fadiman,
Richard Alpert and
Ken Kesey, among others. | ||||
2 | "Psilocybin" | Lucy Walker & Alison Ellwood | July 12, 2022 | |
Topics touched on in the episode on
psilocybin and
psilocybin mushrooms include
psilocybin therapy,
curanderos, the
Seeking the Magic Mushroom article, the
Spring Grove Experiment,
scholarly approaches to mysticism, as well as the
legal status of psilocybin mushrooms and
ego death. Interviewees include
María Sabina,
R. Gordon Wasson, Albert Hofmann, Timothy Leary, William Richards,
Paul Stamets and
Roland Griffiths. | ||||
3 | "MDMA" | Alison Ellwood & Lucy Walker | July 12, 2022 | |
3,4-Methylenedioxymethamphetamine (MDMA) or "ecstasy" is the drug of focus for this episode, with a particular emphasis being placed on themes such as
MDMA-assisted psychotherapy (including
psychedelic treatments for trauma-related disorders), the
Multidisciplinary Association for Psychedelic Studies, as well as
raves and the
Second Summer of Love. Some of the prominent figures being interviewed in this episode are
Ann and
Alexander Shulgin, Ben Sessa and
Rick Doblin. | ||||
4 | "Mescaline" | Alison Ellwood & Lucy Walker | July 12, 2022 | |
The final episode about
mescaline gives insights into
peyote and the
peyote ceremony as administered by
indigenous Americans, such as adherents of the
Native American Church, as well as into the "Decriminalize Nature" movement. It mentions
Echinopsis pachanoi, and the
Eleusinian Mysteries. Some of the interviewees are
Alfred Leo Smith,
Aldous Huxley, Humphry Osmond and Timothy Leary. |
On Rotten Tomatoes, the miniseries holds an approval rating of 100% based on 9 reviews, with an average rating of 7.40/10. [3] Stuart Heritage of The Guardian called the miniseries "hugely eloquent and convincing". [4] Natalia Winkelman of The Boston Globe criticized the series for being too one-sided and failing to adequately address adverse effects of psychedelics. [5] San Francisco Chronicle critic Bob Strauss found the series "not comprehensive, but packed with interesting tidbits" and says it provided "multiple worthy views that can be mind-blowing." [6]